Upgrade to SI Premium - Free Trial

Gilead Sciences (GILD) PT Raised to $90 at RBC Capital

October 28, 2019 6:36 AM
RBC Capital analyst Brian Abrahams raised the price target on Gilead Sciences (NASDAQ: GILD) to $90.00 (from $89.00) while maintaining ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change

Next Articles